↧
The Whistleblower – Pharmaceutical Fraud
In September of 2007, Bristol-Myers Squibb Company and its wholly owned subsidiary, Apothecon, Inc. agreed to pay over $515 million to resolve a broad array of civil allegations involving their drug...
View ArticleThe Dodd-Frank Act Expands the Ability to Pay Higher Whistleblower Awards
One small provision tucked into the Dodd-Frank Wall Street Reform and Consumer Protection Act may have very significant and costly consequences for corporations. Though it hasn’t received as much...
View Article